TOPRA’s 9th annual Pharmaceutical Symposium, organised in conjunction with the irish medicines Board, was held in october in dublin, ireland. representatives from the European Commission, regulatory agencies, industry and academia gathered to debate current regulatory issues and discuss future legislative initiatives
SESSION 1: Scientific advice: an important Strategic activity for all Companies involved in drug development, Especially SmEs
SESSION 2: Clinical trials
SESSION 3: New EU medical device legislation
SESSION 4: The role and activities of the irish medicines Board
SESSION 5: Centralised Procedure
SESSION 6: Self-Care
SESSION 7: Availability of medicines: How to Solve the Challenges
SESSION 8: TOPRA annual review
SESSION 9: Falsified medicines
SESSION 10: Patient information in 2020
SESSION 11: The New Pharmacovigilance legislation – the Experience after implementation
SESSION 3: New EU medical device legislation
SESSION 4: The role and activities of the irish medicines Board
SESSION 5: Centralised Procedure
SESSION 6: Self-Care
SESSION 7: Availability of medicines: How to Solve the Challenges
SESSION 8: TOPRA annual review
SESSION 9: Falsified medicines
SESSION 10: Patient information in 2020
SESSION 11: The New Pharmacovigilance legislation – the Experience after implementation
Reference: TOPRA’s 9th annual Pharmaceutical Symposium
No comments:
Post a Comment